דוסיטקסל טבע ® 20 מ"ג / בקבוקון ו- 80 מ"ג/בקבוקון

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

有效成分:

DOCETAXEL 27.73 MG / 1 ML

可用日期:

ABIC MARKETING LTD

ATC代码:

L01CD02

药物剂型:

CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION

给药途径:

I.V

厂商:

PHARMACHEMIE B.V., THE NETHERLANDS

治疗组:

DOCETAXEL

疗效迹象:

Breast cancerDocetaxel Teva in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.Docetaxel Teva in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.Docetaxel Teva monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. Previous chemotherapy should have included an anthracycline or an alkylating agent.Docetaxel Teva in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours overexpress HER2 and who previously have not received chemotherapy for metastatic disease.Docetaxel Teva in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have inclu

授权日期:

2011-06-01